DOCTOR OBGYN LIMITEDActive

Company number 06693574Private limited companyIncorporated 2008
⚠ Accounts overdue. The next accounts were due on 30 Sep 2025 and had not been filed when the register was last updated.
⚠ Confirmation statement overdue. It was due on 12 Nov 2025.

Key figures

£25,614-65.6%
Net assets 2022/23
-37.8%
Average annual change 2019/20–2022/23
050 k100 k150 k2019/202020/212021/222022/23

Like most small UK companies, DOCTOR OBGYN LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2022/23
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k300 k2019/202020/212021/222022/23
Filed accounts2019/20–2022/23
2019/202020/212021/222022/23
Cash at bank and in hand173,564180,238——
Total assets—233,651235,352233,989
Total liabilities—131,058160,816259,603
Net assets / total equity106,298104,29974,53625,614
Average number of employees0000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: DOCTOR OBGYN LIMITED

Company

DOCTOR OBGYN LIMITED is a private limited company registered with Companies House under company number 06693574. It was incorporated on 10 Sep 2008. Its status is active. The registered office is in London (SE19). Its nature of business (SIC 2007) is specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2022/23 (period ending 30 Sep 2023); the company files micro-entity accounts. Net assets were £25,614, down 65.6% on the previous year. Total assets were £233,989 and total liabilities £259,603. The company had an average of 0 employees. Figures are available for 4 financial years (2019/20–2022/23).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Sep 2025. The next confirmation statement is due by 12 Nov 2025.